Quality of Substance Use History Taking and Drug Screening in Adult Psychiatric Inpatients With Co-Occurring Mental Illness
BJPsych Open · 2026-06 · 12 (S1) · S309-S310
DOI: 10.1192/bjo.2026.11684 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 30.06.2026. Verfasst von Shreyan Kar und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Comorbid substance misuse is common in patients with mental illnesses, which are associated with challenges in diagnosis, management, poor outcomes, and increased risks. National Institute for Health and Care Excellence guidance recommends detailed history taking, biological testing, and early management. This audit aimed to assess the quality of substance use history taking, urine drug screening, and documentation of management plans for adult psychiatric inpatients.
Methods
Clinical audits were completed across four adult psychiatric hospitals in the Black Country Healthcare NHS Foundation Trust in April 2025 and January 2026. Patients were randomly selected and stratified by site and sex. Information about substance use, urine drug screening, type of substances, and management of substance use was collected along with relevant clinical history. The first 48 hours of admission documentation were reviewed. Data were collected using a predesigned questionnaire from the electronic patient records. Following the initial audit, efforts were taken to increase awareness among clinicians and provide recommendations.
Results
There were 40 patients in each of the audits (age range: 19-73 years). Diagnoses were comparable: psychotic disorders (47.5% and 47.5%), mood disorders (40% and 30%), and personality disorders (12.5% and 22.5%). Most patients had a substance use history, 82.5% and 72.5% in the first and second audit, respectively. Urine drug screening within 48 hours of admission increased between cycles (42.5% vs. 50%); with more than half having positive results (58.8% vs. 55%).Commonly used substances were benzodiazepines (45.9%) and tetrahydrocannabinol (18.9%), along with opiates, ketamine, cocaine, and amphetamines. The reasons for lack of screening in the first and second audits were patient refusals (39.5%); there were delayed testing in 9.3%, and no documented reasons in 57.5% of cases. Drug use screening questionnaire usage remained low, but increased from 0% to 5%. There were changes in the documentation of related history such as accommodation (50% vs. 85%, p
Zitieren
APA
Kar, S., Ghafoor, S., & Jabeen, S. (2026). Quality of Substance Use History Taking and Drug Screening in Adult Psychiatric Inpatients With Co-Occurring Mental Illness. BJPsych Open, 12(S1), S309-S310. https://doi.org/10.1192/bjo.2026.11684
Vancouver
Kar S, Ghafoor S, Jabeen S. Quality of Substance Use History Taking and Drug Screening in Adult Psychiatric Inpatients With Co-Occurring Mental Illness. BJPsych Open. 2026;12(S1):S309-S310. doi:10.1192/bjo.2026.11684
BibTeX
@article{Kar2026,
author = {Kar, Shreyan and Ghafoor, Salma and Jabeen, Suneela},
title = {Quality of Substance Use History Taking and Drug Screening in Adult Psychiatric Inpatients With Co-Occurring Mental Illness},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {S1},
pages = {S309--S310},
doi = {10.1192/bjo.2026.11684}
}
EUVIMED